These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9179222

  • 1. Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer.
    Limouris G, Shukla SK, Manetou A, Kouvaris I, Plataniotis G, Triantafyllou N, Rigas AV, Vlahos L.
    Anticancer Res; 1997; 17(3B):1699-704. PubMed ID: 9179222
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
    Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, Smith H, Moulton JS, Williams CC, Ehrhardt GJ.
    J Nucl Med; 1991 Oct; 32(10):1877-81. PubMed ID: 1717669
    [Abstract] [Full Text] [Related]

  • 4. [Pain therapy with rhenium-186 HEDP in multiple bone metastases].
    Palmedo H, Bender H, Schomburg A, Grünwald F, Schöneich G, Zamorra P, Reichmann K, Dierke-Dzierzon C, Mallmann P, Biersack HJ.
    Nuklearmedizin; 1996 Apr; 35(2):63-7. PubMed ID: 8721578
    [Abstract] [Full Text] [Related]

  • 5. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
    Liepe K, Franke WG, Kropp J, Koch R, Runge R, Hliscs R.
    Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
    [Abstract] [Full Text] [Related]

  • 6. Rhenium-186 HEDP: palliative radionuclide therapy of painful bone metastases. Preliminary results.
    Schoeneich G, Palmedo H, Dierke-Dzierzon C, Müller SC, Biersack HJ.
    Scand J Urol Nephrol; 1997 Oct; 31(5):445-8. PubMed ID: 9406304
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Palliation of bone pain in metastatic prostate carcinoma. Value of radionuclide therapy with rhenium 186 HEDP].
    Klutmann S, Bohuslavizki KH.
    MMW Fortschr Med; 1999 Nov 04; 141(44):38-9. PubMed ID: 10912142
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Palliative treatment for pain in osseous metastasized prostatic carcinoma with osteotropic rhenium-186 hydroxyethylidene diphosphonate (HEDP)].
    Holle LH, Humke U, Trampert L, Ziegler M, Kirsch CM, Oberhausen E.
    Urologe A; 1997 Nov 04; 36(6):540-7. PubMed ID: 9487590
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.
    Zafeirakis A, Zissimopoulos A, Baziotis N, Limouris GS.
    Q J Nucl Med Mol Imaging; 2011 Feb 04; 55(1):91-102. PubMed ID: 21068716
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rhenium-188-HEDP in the palliative treatment of bone metastases.
    Liepe K, Hliscs R, Kropp J, Grüning T, Runge R, Koch R, Knapp FF, Franke WG.
    Cancer Biother Radiopharm; 2000 Jun 04; 15(3):261-5. PubMed ID: 10941533
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.